Use of Viagra-type drugs associated with 31% lower risk of death over 7.5 years

Posted by .(JavaScript must be enabled to view this email address)
Thursday, May 10, 2018 1:42 pm Email this article

Men with Type 2 diabetes who were prescribed Viagra-type drugs for improving erections were 31% less likely to die than men of the same age who were not prescribed these drugs during an average follow-up of 7.5 years according to a recent study.

The risk of dying was 46% less after adjusting for age, kidney function, smoking status, prior stroke, hypertension, prior myocardial infarction, systolic blood pressure, use of statin, metformin, aspirin and β-blocker medication,

The study looked at the use of phosphodiesterase type-5 inhibitors which include sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) and avanafil (Stendra).

 

Subjects

Subjects: 5956 men, 40–89 years-old with type 2 diabetes from 42 general practices in Cheshire, UK

The study analyzed data from 5956 men aged 40– to 89-years-old diagnosed with type 2 diabetes between from 42 general practices in Cheshire, UK, and were followed for 7.5 years.

Reference

Anderson SG, Hutchings DC, Woodward M, Rahimi K, Rutter MK, Kirby M, Hackett G, Trafford AW, and Heald AH. Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Heart, 2016 Nov 01; 102(21): 1750-1756.

Author’s Contact Info

Dr Simon G Anderson
Institute of Cardiovascular Sciences
University of Manchester
3.24 Core Technology Facility
46 Grafton Street
Manchester M13 9NT, UK
simon. .(JavaScript must be enabled to view this email address)

Articles on the same subject can be found here:

• Phosphodiesterase type-5 inhibitors, sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra)